Illumina - About the company
Illumina is a public company, founded in 1993 by David Walt, , , and . It operates as a Developer of technologies for analysis of genetic variation and function. Illumina has raised $28M in funding from investors like Dow Chemical Company, Lombard Odier and P E Corporate Services. The company has 534 active competitors, including 58 funded and 82 that have exited. Its top competitors include companies like , PacBio and Arbor Biotechnologies.
Company Details
Developer of technologies for analysis of genetic variation and function. The company provides laboratory instruments, kits, and reagents for research, drug development, and the development of molecular tests. The product categories include gene panel and array finder, microarray kits, clinical research, and IVD products.
- Website
- Social
- Email ID
- @illumina.com
- Phone Number
- +1
Key Metrics
Founded Year
1993
Stage
Public
Total Funding
in 6 rounds
Latest Funding Round
Investors
Ranked
2nd among 534 active competitors
Annual Revenue
as on Dec 31, 2024
Employee Count
as on Dec 31, 2022
Investment & Acquisitions
Truveta &
Similar Companies
&
Exit Details
Public
Legal entities associated with Illumina
Illumina is associated with 3 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Sep 04, 2009 | $4.37B (as on Dec 31, 2024) | 721 | 173 | |
Dec 06, 2011 | - | 686 | 587 | |
May 15, 2000 | $3.33B (as on Dec 31, 2018) | 962 | 379 |
Get your free copy of Illumina's company profile
Illumina's funding and investors
Illumina has raised a total funding of $28M over 6 rounds. Its first funding round was on Jan 10, 2000. Its latest funding round was a Grant (prize money) round on Jan 01, 2020 for an undisclosed amount. 1 investor participated in its latest round, which include Tekla Capital Management, Venrock, Saints Capital and Arch Venture Partners.
Illumina has 32 institutional investors including Dow Chemical Company, Lombard Odier and P E Corporate Services.
Here is the list of recent funding rounds of Illumina:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Jan 01, 2020 | Undisclosed | Grant (prize money) | 2290896 | 1356204 | |
Aug 01, 2019 | $55.4K | Grant (prize money) | 4567055 | 3345312 | |
Aug 01, 2014 | $347K | Grant (prize money) | 2650040 | 4649098 |
Access funding benchmarks and valuations. Sign up today!View details of Illumina's funding rounds and investors
Illumina's founders and board of directors
The founders of Illumina are David Walt, , , and . is the CEO of Illumina. David Walt has founded 1 more company - VIZGEN.
View details of Illumina's Founder profiles and Board Members
Illumina's employee count trend
Illumina has 5,548 employees as of Dec 22. The total employee count is 13.9% more than what it was in Dec 21. Here is Illumina's employee count trend over the years:
Uncover Illumina's growth story! Sign up today!Illumina's Competitors and alternates
Top competitors of Illumina include , PacBio and Arbor Biotechnologies. Here is the list of Top 10 competitors of Illumina, ranked by 秘密研究所 score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | 秘密研究所 Score |
|---|---|---|---|---|---|
1st |  1956, Waltham (United States), Public | Provider of Electron microscopy services | - | - | 81/100 |
2nd | 1993, Public | Developer of technologies for analysis of genetic variation and function | $28M | Tekla Capital Management, Venrock听&补尘辫;听 | 72/100 |
3rd |  PacBio 2004, Menlo Park (United States), Public | Developer of instrument systems and software for real-time sequencing of single-molecules | $327M | - | 75/100 |
4th | Arbor Biotechnologies 2016, Cambridge (United States), Series C | Provider of genomic technologies and drug discovery platform | $304M | - | 73/100 |
5th | Quanterix 2007, Cambridge (United States), Public | Developer of assay kits for ultra-sensitive biomarker detection | $99.5M | - | 71/100 |
6th | Complete Genomics 2006, San Jose (United States), Acquired | Developer of DNA sequencing platform for human genome sequencing and analysis | $125M | - | 69/100 |
7th | Provider of drug research and development services for multiple therapeutic areas | - | - | 69/100 | |
8th | Biocare Medical 1997, Concord (United States), Acquired | Manufacturer of primary antibodies and instruments for immunohistochemistry applications | $85M | - | 69/100 |
9th | BioLife Solutions 1987, Bothell (United States), Public | Developer of tissue hypothermic storage and cryopreservation freeze media | - | - | 68/100 |
10th |  Telesis Bio 2013, San Diego (United States), Public | Online platform offering life sciences reagents and kits | $25M | - | 67/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Illumina's competitors? Click to see the top ones
Illumina's Investments and acquisitions
Illumina has made 64 investments in companies including Truveta and Cache. Illumina has also acquired 17 companies including Fluent BioSciences and IDbyDNA. Here is the list of investments & acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jan 13, 2025 | Investments | 2020 | Seattle, United States | |
Jul 09, 2024 | Acquisition | 2018 | Watertown, United States | |
May 07, 2024 | Investments | 2020 | Chennai, |
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by Illumina
Reports related to Illumina
Here is the latest report on Illumina's sector:
View
News related to Illumina
Media has covered Illumina for a total of 105 events in the last 1 year, 61 of them have been about company updates and 12 about partnerships.
鈥�
鈥�
MarketBeat鈥�Apr 24, 2025鈥�Illumina,
鈥�
MarketBeat鈥�Apr 24, 2025鈥�Illumina,
鈥�
鈥�
MarketBeat鈥�Apr 05, 2025鈥�Illumina,
鈥�
MarketBeat鈥�Apr 01, 2025鈥�Illumina,
鈥�
MarketBeat鈥�Mar 28, 2025鈥�Illumina
鈥�
EndPoints News鈥�Mar 26, 2025鈥�Illumina
鈥�
鈥�
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Illumina
When was Illumina founded?
Illumina was founded in 1993.When was the latest funding round of Illumina?
Illumina's latest funding round was on Jan 01, 2020.What is the annual revenue of Illumina?
Annual revenue of Illumina is $4.37B as on Dec 31, 2024.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Softstack - Unfunded company
- Sportin - Bosnia And Herzegovina based, Unfunded company
- Journal of Educational Innovations and Technology - Jaipur based, Unfunded company
- Gamerboom - Series A company
- Electrogenos - Oxford based, 2022 founded, Funding Raised company
- Zooid tech - Bengaluru based, 2022 founded, Unfunded company
